As the primary caregiver, Kara Deschenes life was dramatically shaken following her husband's diagnosis with prostate cancer. In dealing with the stress associated with the situation, she learned to use healthy channels to balance her feelings.
New listing: Study of Immunotherapy to Treat Advanced Prostate Cancer
Bristol-Myers Squibb (BMS) is conducting a Phase 3 trial using a novel immunotherapy agent in patients with metastatic CRPC that have received prior treatment with docetaxel. Ipilimumab (anti CTLA-4) plus radiotherapy will be compared to placebo plus radiotherapy in this randomized, double-blind study, to determine if ipilimumab prolongs survival in men who have metastatic CRPC. This study is being conducted in over 50 centers across the USA and also in 24 other countries around the world. Click here for a list of additional open trials.
Risk Factors
Make a Donation